IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 10.370-10.530 for the period, compared to the consensus EPS estimate of 10.520. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.
IDEXX Laboratories Stock Up 0.7 %
Shares of IDXX opened at $451.08 on Thursday. The company has a market capitalization of $37.25 billion, a price-to-earnings ratio of 43.67, a PEG ratio of 4.03 and a beta of 1.33. IDEXX Laboratories has a 52 week low of $372.50 and a 52 week high of $583.39. The stock’s 50-day moving average price is $481.87 and its 200-day moving average price is $488.22. The company has a quick ratio of 1.03, a current ratio of 1.37 and a debt-to-equity ratio of 0.33.
IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $2.44 EPS for the quarter, missing analysts’ consensus estimates of $2.88 by ($0.44). IDEXX Laboratories had a return on equity of 57.03% and a net margin of 22.34%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same period in the previous year, the business earned $2.67 EPS. IDEXX Laboratories’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, sell-side analysts predict that IDEXX Laboratories will post 10.44 EPS for the current year.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on IDEXX Laboratories
IDEXX Laboratories Company Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Featured Articles
- Five stocks we like better than IDEXX Laboratories
- 3 Warren Buffett Stocks to Buy Now
- Chipotle Serves Up a Price Dip – The Market Is Buying
- The 3 Best Retail Stocks to Shop for in August
- Bitcoin Breakout: 3 Stocks Set to Ride the Cryptocurrency Wave
- What is a Dividend King?
- Charging Ahead: Investing in the EV Charging Infrastructure
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.